Bristol-Myers Squibb and Pfizer are co-marketing Eliquis, while both companies are noted as dividend payers.

The entities involved

• Bristol-Myers Squibb →

  American pharmaceutical company

  • Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
  • FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09
• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • Dave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Mon 05:00
  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
• Gilead Sciences →

  American company

  • Required regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.Sun 22:40
  • A pilot program is underway involving the federal government, Benue State, and Gilead Sciences, with the state participating in the drug supply management.Sat 01:51

Related events

• Cocrystal Pharma and Bristol-Myers Squibb are competing for investment as healthcare companies.Sun 22:20
• Bristol-Myers Squibb has taken ownership of Celgene's drug.Jun 7
• Bristol-Myers Squibb and Johnson & Johnson are both companies that are currently targets of LB Pharmaceuticals.Sep 9
• Pfizer and Eli Lilly are being discussed as potential dividend investment targets.Sep 22
• Pfizer is jointly marketing the drug Eliquis.Jun 13